SCHEMBL8485409

SCHEMBL8485409

O=C(O)c1ccccc1NC(=S)Cc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.63
▸ L3MBTL1 Q9Y468 1/20 0.63
▸ ABCC1 P33527 5/20 0.58
▸ CFD P00746 1/20 0.58
▸ MASP2 O00187 1/20 0.55
▸ KDM4E B2RXH2 2/20 0.55
▸ LMNA P02545 2/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ KMT2A Q03164 3/20 0.51
▸ MEN1 O00255 2/20 0.49
▸ KDM6B O15054 1/20 0.49
▸ KDM4D Q6B0I6 1/20 0.49
▸ KDM4C Q9H3R0 1/20 0.49
▸ POLB P06746 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ NPC1 O15118 1/20 0.48
▸ RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9473974 0.86 ALDH1A1 (0.57) ALDH1A1L3MBTL1ABCC1CFDMASP2
SCHEMBL4040223 0.83 ALDH1A1 (0.82) ALDH1A1L3MBTL1ABCC1CFDKDM4E
SCHEMBL8437112 0.81 ALDH1A1 (0.79) ALDH1A1L3MBTL1ABCC1CFDKDM4E
SCHEMBL5696443 0.78 ALDH1A1 (0.73) ALDH1A1L3MBTL1CFDKDM4ELMNA
SCHEMBL14855999 0.78 ALDH1A1 (0.73) ALDH1A1L3MBTL1CFDKDM4ELMNA
SCHEMBL7427911 0.78 ALDH1A1 (0.60) ALDH1A1L3MBTL1ABCC1CFDKDM4E
SCHEMBL9475280 0.77 POLB (0.54) ALDH1A1KDM4ELMNASMN1; SMN2POLB
SCHEMBL9251459 0.77 ALDH1A1 (0.59) ALDH1A1L3MBTL1KDM4ELMNASMN1; SMN2
SCHEMBL22524956 0.76 ABCC1 (0.55) ALDH1A1L3MBTL1ABCC1CFDMASP2
SCHEMBL8511541 0.76 HDAC1 (0.49) ALDH1A1KDM4ELMNASMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5925647-A TREATMENT OF INSULIN NON-INSULIN DEPENDENT DIABETES SHAMAN PHARMACEUTICALS, INC. (US) 1999-07-20 — — US disclosed
US-5681958-A TREATMENT OF DIABETES SHAMAN PHARMACEUTICALS, INC. (US) 1997-10-28 — — US disclosed
WO-1996010015-A1 CRYPTOLEPINE ANALOGS WITH HYPOGLYCEMIC ACTIVITY SHAMAN PHARMACEUTICALS, INC. (US) 1996-04-04 — — WO disclosed
Send feedback